(Q40297448)

English

Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells

scientific article published on 31 March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

oncolytic virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Akseli Hemminki

12

object named as

Akseli Hemminki

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Tanja Hakkarainen

9

object named as

Tanja Hakkarainen

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

David T. Curiel

11

object named as

David T Curiel

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

3

object named as

Anna Kanerva

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Gerd J Bauerschmitz

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Kilian Guse

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Artur Menzel

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Isabell Herrmann

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Renee A Desmond

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Masato Yamamoto

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Dirk M Nettelbeck

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Peter Dall

10

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

31 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Molecular Therapy

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

164-174

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Adenoviruses in oncology: a viable option?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Cancer cell cycles

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Human papillomavirus E6E7-mediated adenovirus cell killing: selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Why did p53 gene therapy fail in ovarian cancer?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Transductional and transcriptional targeting of adenovirus for clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroids

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Replicative adenoviruses for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

A 50-kDa membrane protein mediates sialic acid-independent binding and infection of conjunctival cells by adenovirus type 37.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Generation of an adenoviral vector containing an addition of a heterologous ligand to the serotype 3 fiber knob

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.010

7 January 2021

Identifiers

10.1016/J.YMTHE.2006.01.010

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40297448&oldid=2117430202"